Association between metformin adherence groups and the rate of clinical events in the study population
| Clinical events . | Adherence to metformin (MPR) . | |||
|---|---|---|---|---|
| MPR <40%, n = 42 . | MPR ≥40% to <80%, n = 49 . | MPR ≥80%, n = 37 . | P . | |
| Rate of all-cause inpatient encounters per year, median (IQR) | 1 (0-2) | 0 (0-1) | 0 (0-1) | .13 |
| All-cause inpatient encounters ≥1, n (%) | 22 (52) | 16 (33) | 16 (43) | .16 |
| Rate of inpatient encounters with SCD codes per year, median (IQR) | 0 (0-1) | 0 (0-0) | 0 (0-0) | <.01 |
| Inpatient encounters with SCD codes ≥1, n (%) | 15 (36) | 6 (12) | 4 (11) | <.01 |
| Rate of all-cause ED encounters per year, median (IQR) | 2 (1-7) | 1 (1-4) | 1 (1-4) | .17 |
| All-cause ED encounters ≥1, n (%) | 34 (81) | 37 (76) | 28 (76) | .79 |
| Rate of ED encounters with SCD codes per year, median (IQR) | 0 (0-1) | 0 (0-0) | 0 (0-0) | .19 |
| ED encounters with SCD codes ≥1, n (%) | 11 (26) | 10 (20) | 4 (11) | .22 |
| Clinical events . | Adherence to metformin (MPR) . | |||
|---|---|---|---|---|
| MPR <40%, n = 42 . | MPR ≥40% to <80%, n = 49 . | MPR ≥80%, n = 37 . | P . | |
| Rate of all-cause inpatient encounters per year, median (IQR) | 1 (0-2) | 0 (0-1) | 0 (0-1) | .13 |
| All-cause inpatient encounters ≥1, n (%) | 22 (52) | 16 (33) | 16 (43) | .16 |
| Rate of inpatient encounters with SCD codes per year, median (IQR) | 0 (0-1) | 0 (0-0) | 0 (0-0) | <.01 |
| Inpatient encounters with SCD codes ≥1, n (%) | 15 (36) | 6 (12) | 4 (11) | <.01 |
| Rate of all-cause ED encounters per year, median (IQR) | 2 (1-7) | 1 (1-4) | 1 (1-4) | .17 |
| All-cause ED encounters ≥1, n (%) | 34 (81) | 37 (76) | 28 (76) | .79 |
| Rate of ED encounters with SCD codes per year, median (IQR) | 0 (0-1) | 0 (0-0) | 0 (0-0) | .19 |
| ED encounters with SCD codes ≥1, n (%) | 11 (26) | 10 (20) | 4 (11) | .22 |